Try our mobile app

General information

MD Medical Group Investments PLC is a private healthcare provider in Russia. The Company specializes in women's and children's healthcare.
  • Good financial results growth rate 23.0% (average between last period year over year growth for revenue and EBITDA), there is acceleration compared to average historical growth rates (10.6%)
  • Dividend yield for the last twelve months 17.3%
  • Free cash flow yield 9.2% (LTM)
  • Share price is 228.7% higher than minimum and 11.3% lower than maximum for the last 3 years
  • The company is overvalued by EV / LTM EBITDA multiple compared to target level (6.5x vs
    )
  • Fundamental value created in LTM (estimate)
  • Taking into account the impact of the key rate 21% on the change in financial parameters: EBITDA adjustment is 1 302 mln rub as NetDebt * (current key rate - normalized 7%) / 2, expected EBITDA adjusted for key rate increases is 13 271 mln rub, expected mult is 4.6x, target mult is 4.5x, potential is -1.8%

Key Financials (Download financials)

Ticker: MDMG
Share price, RUB:  (+0.8%)1060.3
year average price 937.38  


year start price 990.00 2024-03-29

max close price 1196.00 2024-05-14

min close price 799.00 2024-07-05

current price 1067.00 2025-03-28
Common stocks: 75 130 000

Dividend Yield:  17.3%
FCF Yield LTM: 9.2%
EV / LTM EBITDA: 6.5x
EV / EBITDA annualized: 6.6x
Last revenue growth (y/y):  22.6%
Last growth of EBITDA (y/y):  23.5%
Historical revenue growth:  10.0%
Historical growth of EBITDA:  11.3%
Target EV / EBITDA (hist percentile):
Express share price potential:
Fundamental value created in LTM:
Fundamental value created in LTM:
 Mult Upside-22.3%
 FCF Creation+9.2%
 Growth+23.0%
 Growth Corr+6.2%
 
 Sum+16.2%
EV / LTM EBITDA mutiple calculation
Market Cap (m RUB): 79 660
Net Debt (m RUB): -13 158
EV (Enterprise Value): 66 502
EBITDA LTM (m RUB): 10 180
Net Income LTM (m RUB): 7 823
EV / LTM EBITDA: 6.5x
Net Debt / LTM EBITDA (if EBITDA > 0): -1.3x
Average daily trading volume for the week, RUB mln: 385
P / E 10.6x
P / B 2.3x

Revenue and EBITDA

Semi-Annual values (m RUB)

Change (y/y)

Cash Flow

FCF (m RUB), before FX effects elimination

Net Debt / Cash and Equivalents (m RUB)

Share price and dividends (Download history)

Share price

Payment RUB per share

Multiple and potential

EV / LTM EBITDA and 50% percentile

Potential dynamics

Daily trade volumes

Millions of RUB

P/B and P/E multipliers

P / B

P / E

More information for subscribed users:
detailed calculation of
Potential and Created Value,
commodities affecting the company